A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients

NCT03629080 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus (CMV) Infection
Kidney Transplantation

Interventions

BIOLOGICAL: HB-101 vaccine
BIOLOGICAL: placebo

Sponsor

Hookipa Biotech GmbH